Oscotec Inc. (039200.KQ)
KRW 24450.0
(-2.4%)
KRW 24450.0
(-2.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -30.02 Billion KRW | -14.61% |
| 2022 | -26.02 Billion KRW | -1.22% |
| 2021 | -27.01 Billion KRW | -62089.83% |
| 2020 | 2.64 Billion KRW | 99.8% |
| 2019 | -20.81 Billion KRW | -428.49% |
| 2018 | 6.78 Billion KRW | 218.17% |
| 2017 | -5.56 Billion KRW | -291.85% |
| 2016 | -6.26 Billion KRW | -217.26% |
| 2015 | 1.19 Billion KRW | 446.91% |
| 2014 | -1.1 Billion KRW | 27.6% |
| 2013 | -2.79 Billion KRW | -122.54% |
| 2012 | -5.36 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -7.5 Billion KRW | 56.51% |
| 2024 Q2 | -6.88 Billion KRW | -1.68% |
| 2023 Q1 | -7.06 Billion KRW | -31.35% |
| 2023 Q3 | -7.58 Billion KRW | -17.59% |
| 2023 Q4 | -9.7 Billion KRW | -28.03% |
| 2023 FY | - KRW | -14.61% |
| 2023 Q2 | -6.44 Billion KRW | 8.73% |
| 2022 Q4 | -5.37 Billion KRW | 23.82% |
| 2022 Q3 | -7.06 Billion KRW | -13.32% |
| 2022 Q1 | -8.24 Billion KRW | -98.51% |
| 2022 FY | - KRW | -1.22% |
| 2022 Q2 | -6.23 Billion KRW | 24.47% |
| 2021 Q2 | -5.7 Billion KRW | 43.38% |
| 2021 Q4 | -4.15 Billion KRW | 37.22% |
| 2021 Q1 | -10.07 Billion KRW | -207.19% |
| 2021 FY | - KRW | -62089.83% |
| 2021 Q3 | -6.61 Billion KRW | -16.04% |
| 2020 Q2 | 7.5 Billion KRW | 209.53% |
| 2020 Q1 | -6.85 Billion KRW | -11.12% |
| 2020 Q4 | 9.39 Billion KRW | 226.85% |
| 2020 FY | - KRW | 99.8% |
| 2020 Q3 | -7.4 Billion KRW | -198.69% |
| 2019 Q2 | -6.66 Billion KRW | -49.11% |
| 2019 FY | - KRW | -428.49% |
| 2019 Q4 | -6.16 Billion KRW | -53.92% |
| 2019 Q3 | -4 Billion KRW | 39.84% |
| 2019 Q1 | -4.46 Billion KRW | -134.99% |
| 2018 Q1 | -768.53 Million KRW | 61.44% |
| 2018 Q3 | -4.15 Billion KRW | -207.79% |
| 2018 FY | - KRW | 218.17% |
| 2018 Q4 | 12.76 Billion KRW | 406.87% |
| 2018 Q2 | -1.35 Billion KRW | -75.86% |
| 2017 FY | - KRW | -291.85% |
| 2017 Q3 | -1.32 Billion KRW | -19.57% |
| 2017 Q4 | -1.99 Billion KRW | -50.09% |
| 2017 Q2 | -1.11 Billion KRW | -5.19% |
| 2017 Q1 | -1.05 Billion KRW | 76.75% |
| 2016 Q3 | -480.01 Million KRW | 38.55% |
| 2016 Q1 | -462.37 Million KRW | -212.65% |
| 2016 Q2 | -781.16 Million KRW | -68.95% |
| 2016 FY | - KRW | -217.26% |
| 2016 Q4 | -4.54 Billion KRW | -846.01% |
| 2015 Q3 | 1.32 Billion KRW | 397.25% |
| 2015 Q4 | 410.46 Million KRW | -69.1% |
| 2015 Q2 | -446.9 Million KRW | -357.87% |
| 2015 Q1 | -97.6 Million KRW | 82.48% |
| 2015 FY | - KRW | 446.91% |
| 2014 Q1 | 5.43 Million KRW | 100.24% |
| 2014 FY | - KRW | 27.6% |
| 2014 Q4 | -557.05 Million KRW | -556.32% |
| 2014 Q3 | 122.07 Million KRW | 43.18% |
| 2014 Q2 | 85.26 Million KRW | 1469.88% |
| 2013 Q2 | 383.34 Million KRW | -66.5% |
| 2013 Q3 | 261.7 Million KRW | -31.73% |
| 2013 Q1 | 1.14 Billion KRW | 87.58% |
| 2013 Q4 | -2.26 Billion KRW | -965.42% |
| 2013 FY | - KRW | -122.54% |
| 2012 Q4 | 609.99 Million KRW | -25.19% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q3 | 815.4 Million KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BCWORLD PHARM. Co., Ltd. | 14.13 Billion KRW | 312.416% |